• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chairman, Co-CEO and Co-Pres Preston Stephen bought $66,340 worth of shares (3,540 units at $18.74) and sold $66,269 worth of shares (3,540 units at $18.72) (SEC Form 4)

    10/17/24 5:00:04 PM ET
    $FVR
    Real Estate Investment Trusts
    Real Estate
    Get the next $FVR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Preston Stephen

    (Last) (First) (Middle)
    C/O FRONTVIEW REIT, INC.
    3131 MCKINNEY AVE., SUITE L10

    (Street)
    DALLAS TX 75204

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    FrontView REIT, Inc. [ FVR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Chairman, Co-CEO and Co-Pres
    3. Date of Earliest Transaction (Month/Day/Year)
    10/15/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock(1) 10/15/2024 P 3,540 A $18.74 3,640 D
    Common Stock(1) 10/16/2024 S 3,540 D $18.72(2) 100 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. The reporting person mistakenly completed a purchase of shares of the Issuer's common stock on October 15, 2024, and promptly corrected the purchase by selling the same number of shares as soon as practicably possible, with such sale occurring on October 16, 2024. The reporting person acknowledges that the transactions reported herein are matchable under Section 16(b) of the Securities Exchange Act of 1984, as amended (the "Exchange Act"). However, because the aggregate sales price for the reported transaction on October 16, 2024 was less than the aggregate purchase price for the reported transaction on October 15, 2024, no profit was realized by the reporting person and no amount is subject to disgorgement under Section 16(b) of the Exchange Act.
    2. These shares of the Issuer's common stock were sold in multiple transactions at prices ranging from $18.6158 to $18.7447, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.
    /s/ Stephen Preston 10/17/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FVR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FVR

    DatePrice TargetRatingAnalyst
    6/17/2025$12.00Overweight → Neutral
    Analyst
    5/6/2025$15.00Buy → Neutral
    BofA Securities
    11/12/2024$22.00Overweight
    CapitalOne
    10/28/2024$22.00Overweight
    Wells Fargo
    10/28/2024$21.00Overweight
    JP Morgan
    10/28/2024$23.00Overweight
    Morgan Stanley
    10/28/2024$22.00Buy
    BofA Securities
    More analyst ratings